2003
DOI: 10.1002/glia.10208
|View full text |Cite
|
Sign up to set email alerts
|

Metallothionein‐I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte‐targeted interleukin‐6 expression

Abstract: Transgenic expression of IL-6 in the CNS under the control of the GFAP gene promoter, glial fibrillary acidic protein-interleukin-6 (GFAP-IL-6) mice, raises an inflammatory response and causes significant brain damage. However, the results obtained in the GFAP-IL-6 mice after a traumatic brain injury, such as a cryolesion, demonstrate a neuroprotective role of IL-6. Thus, the GFAP-IL-6 mice showed faster tissue repair and decreased oxidative stress and apoptosis compared with control litter-mate mice. The neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
44
0
1

Year Published

2004
2004
2011
2011

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 39 publications
(51 citation statements)
references
References 73 publications
6
44
0
1
Order By: Relevance
“…In contrast, transgenic mice over expressing MT I/II displayed less severe inflammatory responses of macrophages and lymphocytes including decreased levels of pro-inflammatory cytokines and ROS [43,47,48]. In agreement with the findings described in MS that increased levels of MT are involved in disease remission and clinical recovery [49,50], we found a significant increase in MT I/II mRNA and protein levels in cuprizone-induced demyelinated brain and MTII mRNA in GFs-induced remyelination. The expression of MT was primarily associated with the astrocytes, while a low level was also detected in activated microglia [51][52][53].…”
Section: Discussionsupporting
confidence: 91%
“…In contrast, transgenic mice over expressing MT I/II displayed less severe inflammatory responses of macrophages and lymphocytes including decreased levels of pro-inflammatory cytokines and ROS [43,47,48]. In agreement with the findings described in MS that increased levels of MT are involved in disease remission and clinical recovery [49,50], we found a significant increase in MT I/II mRNA and protein levels in cuprizone-induced demyelinated brain and MTII mRNA in GFs-induced remyelination. The expression of MT was primarily associated with the astrocytes, while a low level was also detected in activated microglia [51][52][53].…”
Section: Discussionsupporting
confidence: 91%
“…Cell counts were performed from three sections per mouse in all mice. Positively vs. negatively stained cells were previously demonstrated in detail Penkowa et al, 2003).…”
Section: Cell Countsmentioning
confidence: 95%
“…In addition to neurotrophin induction, the neuropoietic cytokines like IL-6 have been shown to possess additional mechanisms of neuroprotection in TBI models, by mediating the generation of antioxidants, such as metallothioneins [113,181]. Furthermore, the intracranial activation of the complement cascade has been shown to mediate neuroprotective effects aside from the previously known neuroinflammatory and deleterious functions [135,140,166].…”
Section: Dual Role Of the Inflammatory Responsementioning
confidence: 99%